SCHEMBL5848460

SCHEMBL5848460

CCCNCC(O)c1ccc(Br)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 2/20 0.48
KDM4E B2RXH2 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ALDH1A1 P00352 5/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CYP2C9 P11712 2/20 0.42
HIF1A Q16665 2/20 0.42
HTR1A P08908 1/20 0.42
THPO P40225 1/20 0.42
BLM P54132 1/20 0.42
NMUR2 Q9GZQ4 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
TAAR1 Q96RJ0 1/20 0.42
ABCB1 P08183 2/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A3 Q01959 2/20 0.41
SLC6A2 P23975 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27731715 0.85 HIF1A (0.53) ADRB2KDM4EL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL2290323 0.85 HIF1A (0.53) ADRB2KDM4EL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL2292671 0.85 HIF1A (0.53) ADRB2KDM4EL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL5847939 0.84 ALDH1A1 (0.47) ADRB2KDM4EL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL6458210 0.84 HIF1A (0.61) ADRB2KDM4EL3MBTL1ALDH1A1SMN1; SMN2
Benzene SCHEMBL27711181 0.82 KDM4E (0.55) ADRB2KDM4EL3MBTL1ALDH1A1SMN1; SMN2
Benzene SCHEMBL27703358 0.82 KDM4E (0.55) ADRB2KDM4EL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL5848458 0.82 AOC3 (0.46) ADRB2KDM4EL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL5847906 0.82 AOC3 (0.46) ADRB2KDM4EL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL9677979 0.81 KDM4E (0.70) ADRB2KDM4EL3MBTL1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7112605-B2 Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof Research Institute of Materia Medica Chinese Acadamy of Medical Sciences (CN) 2006-09-26 US disclosed
US-20040029951-A1 Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof RESEARCH INSTITUTE OF MATERIAL MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES; 2004-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040029951-A1 Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof PTGS1, PTGS2, PTGER1 ADRB2 768/4885KDM4E 1122/4885L3MBTL1 3651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.